Jeffrey Krieger, PhD

Dr. Jeffrey Krieger joined Peptimmune in 2003 as prinicipal scientist in pharmacology/immunology with more than fifteen years experience in pharmaceutical development. Prior to Peptimmune, Dr. Krieger was the head of immunology research at AutoImmune, Inc. and an instructor in the Department of Neurology at The Brigham and Women's Hospital Harvard Medical School, where he held leadership positions in the field of cellular immunology. Jeffrey received a PhD in Immunochemistry from Thomas Jefferson University in Philadelphia and was a postdoctoral fellow in the laboratory of Dr. Howard Grey at National Jewish Hospital in Denver. Jeffrey has published extensively in peer-reviewed scientific journals and been invited to present talks at national and international conferences.